- Adults (18-64 years)
- General population
- Hospital
- Outpatient clinic
- Monkeypox virus
Population: Adults (18-64 years)
- Adults (18-64 years)
- General population
- Community
- Non-hospital health centre
- SARS-CoV-2
- Post COVID-19 condition
- Post-acute infection syndrome
- Adults (18-64 years)
- Hospital
- Emergency department
- SARS-CoV-2
- Blood sample
- Nasopharyngeal swab
- Urine sample
- Adults (18-64 years)
- Hospital
- Primary care
- Emergency department
- Non-hospital health centre
- Long-term care facility
- SARS-CoV-2
- Post COVID-19 condition
- Post-acute infection syndrome
- Blood sample
- Nasopharyngeal swab
- Adults (18-64 years)
- Hospital
- Emergency department
- SARS-CoV-2
- Blood sample
- Nasopharyngeal swab
- PBMC
- Serum
- Stool sample
- Whole blood
- Adults (18-64 years)
- Hospital
- Outpatient clinic
- Community
- Primary care
- SARS-CoV-2
- Post COVID-19 condition
- Post-acute infection syndrome
- Blood sample
- Nasopharyngeal swab
- PBMC
- Serum
- Stool sample
- Whole blood
- Plasma
- Adults (18-64 years)
- Monkeypox virus
- Adults (18-64 years)
- Hospital
- Emergency department
- SARS-CoV-2
- Syndromic diagnostic testing
- Adults (18-64 years)
- Hospital
- Primary care
- SARS-CoV-2
- Influenza virus
- Blood sample
- PBMC
- Serum
- Whole blood
- Plasma
- Adults (18-64 years)
- General population
- Primary care
- Monkeypox virus
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Hospital
- Outpatient clinic
- SARS-CoV-2
- Post COVID-19 condition
- Post-acute infection syndrome
- Adults (18-64 years)
- General population
- Hospital
- Outpatient clinic
- Monkeypox virus
- Pharmacological intervention
- Antivirals
- Cidofovir